To the Editor: The incidence of lung cancer and the five‐year survival of patients diagnosed with lung cancer reflect the social gradient within the Australian society. Most notably, Aboriginal and Torres Strait Islander people are twice as likely to develop lung cancer and half as likely to survive lung cancer.1 Reducing inequity in lung cancer outcomes was a key objective of Cancer Australia when it proposed a National Lung Cancer Screening Program (NLCSP) in 2020, following an enquiry that consulted both medical experts and the broader community.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Cancer Australia. Report on the Lung Cancer Screening enquiry. Sydney: Cancer Australia, 2020. https://www.canceraustralia.gov.au/publications‐and‐resources/cancer‐australia‐publications/report‐lung‐cancer‐screening‐enquiry (viewed Mar 2023).
- 2. Medical Services Advisory Committee. Public summary document — March–April 2022. Application No. 1699 — National Lung Cancer Screening Program. Canberra: MSAC, 2022. http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1699‐public (viewed Mar 2023).
- 3. Medical Services Advisory Committee. Public summary document — July 2022. Application No. 1699 — National Lung Cancer Screening Program. Canberra: MSAC, 2022. http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1699‐public (viewed Mar 2023).
- 4. Evidencio. PLCOm2012: selection criteria for lung cancer screening. Haaksbergen, The Netherlands: Evidencio, 2023. https://www.evidencio.com/models/show/992 (viewed Mar 2023).
- 5. Cressman S, Weber MF, Ngo PJ, et al. Economic impact of using risk models for eligibility selection to the International Lung Screening Trial. Lung Cancer 2023; 176: 38‐45.
No relevant disclosures.